Cargando…
Is the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin?
Eight to 10 million people in 21 endemic countries are infected with Trypanosoma cruzi. However, only 30% of those infected develop symptoms of Chagas’ disease, a chronic, neglected tropical disease worldwide. Similar to other pathogens, T. cruzi has evolved to resist the host immune response. Studi...
Autores principales: | Ramírez-Toloza, Galia, Abello, Paula, Ferreira, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939398/ https://www.ncbi.nlm.nih.gov/pubmed/27462315 http://dx.doi.org/10.3389/fimmu.2016.00268 |
Ejemplares similares
-
Is it all That Bad When Living with an Intracellular Protozoan? The Role of Trypanosoma cruzi Calreticulin in Angiogenesis and Tumor Growth
por: Ramírez-Toloza, Galia, et al.
Publicado: (2015) -
Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin
por: Ramírez-Toloza, Galia, et al.
Publicado: (2017) -
Antiangiogenic and Antitumor Effects of Trypanosoma cruzi Calreticulin
por: López, Nandy C., et al.
Publicado: (2010) -
Does native Trypanosoma cruzi calreticulin mediate growth inhibition of a mammary tumor during infection?
por: Abello-Cáceres, Paula, et al.
Publicado: (2016) -
Is It Possible to Intervene in the Capacity of Trypanosoma cruzi to Elicit and Evade the Complement System?
por: Ramírez-Toloza, Galia, et al.
Publicado: (2021)